Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank78
3Y CAGR+26.5%
5Y CAGR+7.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+26.5%/yr
vs +17.8%/yr prior
5Y CAGR
+7.5%/yr
Recent acceleration
Acceleration
+8.7pp
Accelerating
Percentile
P78
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $35.22M | -40.1% |
| 2024 | $58.82M | +24.3% |
| 2023 | $47.30M | +171.8% |
| 2022 | $17.41M | -35.5% |
| 2021 | $26.98M | +10.1% |
| 2020 | $24.51M | +70.4% |
| 2019 | $14.39M | +58.9% |
| 2018 | $9.05M | +1145.1% |
| 2017 | $727000.00 | +256.4% |
| 2016 | $204000.00 | - |